(Q38217732)

31 August 2017

title

New therapies for coronary artery disease: genetics provides a blueprint (English)

1 reference

31 August 2017

main subject

coronary artery disease

1 reference

Daniel J Rader

1

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 June 2014

1 reference

Science Translational Medicine

31 August 2017

published in

1 reference

31 August 2017

volume

6

1 reference

31 August 2017

issue

239

1 reference

31 August 2017

page(s)

239ps4

1 reference

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Effects of dalcetrapib in patients with a recent acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Validating therapeutic targets through human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Low-density lipoprotein cholesterol reduction by inhibition of PCSK9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Common variants associated with plasma triglycerides and risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Dysfunctional nitric oxide signalling increases risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008535

10.1126/SCITRANSLMED.3008535

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference